EX-10.3
from 8-K
6 pages
Side Letter Relating to an Up to Eur 20,000,000 Accordion Tranche Between and Dated: IO Biotech Aps as Borrower European Investment Bank as Bank 19 December 2024 Side Letter to Finance Contract This Side Letter (The “Letter”) Is Made on the Date First Stated Above Between: 1) IO Biotech Aps, Company Registration No. (Cvr) 36474483, C/O Cobis, Ole Maaløes Vej 3, 2200 København N, Denmark (The “Borrower”) as Borrower, and 2) the European Investment Bank, 100 Blvd Konrad Adenauer, Luxembourg, L-2950 Luxembourg (The “Bank”) as Lender. the Bank and the Borrower Together Are Referred to as the “Parties” and Any of Them Is a “Party”. 1. Background
12/34/56
EX-10.16
from S-1/A
9 pages
Service Agreement This Service Agreement Is Entered Into Between: IO Biotech Aps [***] (The “Company”) and Eva Ehrnrooth (The “Cmo”) 1 Commencement of Employment and Title 1.1 With Effect From 1 October 2017, the Cmo Will Be Employed as Chief Medical Officer (Cmo) in the Company on the Terms and Conditions Set Forth in This Service Agreement (The “Agreement”). 1.2 the Cmo Reports to CEO Mai-Britt Zocca. 2 the Duties of the Cmo 2.1 the Cmo Is in Co-Operation With the Other Members of Management Responsible for the Daily Management of the Company’s Medical Strategy Subject to the Instructions and Guidelines Issued by the CEO and in Accordance With the Job Description, Cf. Clause 2.4. 2.2 Due to the Nature Other Position, It Is the Responsibility of the Cmo to Ensure That Her Area of Business Is at All Times Operated in Accordance With the Company’s Policies and Applicable Law. 2.3 Due to the Nature of Her Position, the Cmo Is Entitled to Sign on Behalf of the Company in Matters Concerning Her Area of Business, to the Extent Agreed With the CEO. All Questions of Extraordinary Character or Major Importance to the Company Shall Be Submitted by the Cmo to the CEO. 2.4 the Cmo’s Duties and Objectives Are to Be Described in a Separate Document, Which Constitutes an Appendix to This Agreement. 3 Place of Work
12/34/56
